Search

everythinglearnresearchcommunity

for

Search:↓

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finasteride safely lowers DHT levels without affecting testosterone.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

More body hair in young Australian women is linked to higher androstenedione levels.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Progesterone helps adult male mice grow more neurons and improves memory.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Hair loss in postmenopausal woman caused by ovarian issue.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.